WO2008133127A1 - 縮合へテロ環誘導体、それを含有する医薬組成物及びその医薬用途 - Google Patents
縮合へテロ環誘導体、それを含有する医薬組成物及びその医薬用途 Download PDFInfo
- Publication number
- WO2008133127A1 WO2008133127A1 PCT/JP2008/057391 JP2008057391W WO2008133127A1 WO 2008133127 A1 WO2008133127 A1 WO 2008133127A1 JP 2008057391 W JP2008057391 W JP 2008057391W WO 2008133127 A1 WO2008133127 A1 WO 2008133127A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- derivative
- pharmaceutical composition
- alkyl
- composition
- fused heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pregnancy & Childbirth (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002682519A CA2682519A1 (en) | 2007-04-18 | 2008-04-16 | Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
EP08740472.9A EP2147922B1 (en) | 2007-04-18 | 2008-04-16 | Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
JP2009511815A JP5352449B2 (ja) | 2007-04-18 | 2008-04-16 | 縮合へテロ環誘導体、それを含有する医薬組成物及びその医薬用途 |
US12/595,931 US8426427B2 (en) | 2007-04-18 | 2008-04-16 | Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-108935 | 2007-04-18 | ||
JP2007108935 | 2007-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008133127A1 true WO2008133127A1 (ja) | 2008-11-06 |
Family
ID=39925583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/057391 WO2008133127A1 (ja) | 2007-04-18 | 2008-04-16 | 縮合へテロ環誘導体、それを含有する医薬組成物及びその医薬用途 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8426427B2 (ja) |
EP (1) | EP2147922B1 (ja) |
JP (1) | JP5352449B2 (ja) |
CA (1) | CA2682519A1 (ja) |
WO (1) | WO2008133127A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225067A (zh) * | 2011-04-29 | 2011-10-26 | 济南环肽医药科技有限公司 | 一种治疗胃癌的药物组合物 |
WO2014030743A1 (ja) | 2012-08-24 | 2014-02-27 | 武田薬品工業株式会社 | 複素環化合物 |
WO2014042176A1 (ja) * | 2012-09-14 | 2014-03-20 | キッセイ薬品工業株式会社 | 縮合複素環誘導体の製造方法およびその製造中間体 |
CN115232144A (zh) * | 2021-04-22 | 2022-10-25 | 长春金赛药业有限责任公司 | 含氮稠环类衍生物、药物组合物及其制备方法和应用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104817541B (zh) * | 2015-05-11 | 2017-06-16 | 苏州东南药业股份有限公司 | 一种抗肿瘤药物的合成方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06510992A (ja) | 1991-09-20 | 1994-12-08 | ビーエーエスエフ アクチェンゲゼルシャフト | 置換3−フェニルウラシル |
WO1995028405A1 (en) * | 1994-04-19 | 1995-10-26 | Takeda Chemical Industries, Ltd. | Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists |
WO1996024597A1 (en) | 1995-02-08 | 1996-08-15 | Takeda Chemical Industries, Ltd. | Thienopyrimidine derivatives, their production and use |
WO2001055119A2 (en) * | 2000-01-25 | 2001-08-02 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
US20030004167A1 (en) | 1998-12-23 | 2003-01-02 | Lam Patrick Y. | Imidazo-heterobicycles as factor Xa inhibitors |
WO2005019188A1 (ja) | 2003-08-22 | 2005-03-03 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
WO2006083005A1 (ja) | 2005-02-03 | 2006-08-10 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
WO2007046392A1 (ja) * | 2005-10-19 | 2007-04-26 | Kissei Pharmaceutical Co., Ltd. | 縮合複素環誘導体、それを含有する医薬組成物及びその医薬用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69622648T2 (de) | 1995-02-10 | 2003-02-27 | Suntory Ltd Osaka | Benzoxalepin-derivate, deren salze und diese enthaltende arzneimittel |
WO2005055118A2 (en) * | 2003-11-29 | 2005-06-16 | Cross Match Technologies, Inc. | Polymer ceramic slip and method of manufacturing ceramic green bodies therefrom |
US20070010537A1 (en) | 2004-08-20 | 2007-01-11 | Kazumasa Hamamura | Fused pyramidine derivative and use thereof |
-
2008
- 2008-04-16 WO PCT/JP2008/057391 patent/WO2008133127A1/ja active Application Filing
- 2008-04-16 JP JP2009511815A patent/JP5352449B2/ja not_active Expired - Fee Related
- 2008-04-16 EP EP08740472.9A patent/EP2147922B1/en active Active
- 2008-04-16 US US12/595,931 patent/US8426427B2/en active Active
- 2008-04-16 CA CA002682519A patent/CA2682519A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06510992A (ja) | 1991-09-20 | 1994-12-08 | ビーエーエスエフ アクチェンゲゼルシャフト | 置換3−フェニルウラシル |
WO1995028405A1 (en) * | 1994-04-19 | 1995-10-26 | Takeda Chemical Industries, Ltd. | Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists |
WO1996024597A1 (en) | 1995-02-08 | 1996-08-15 | Takeda Chemical Industries, Ltd. | Thienopyrimidine derivatives, their production and use |
US20030004167A1 (en) | 1998-12-23 | 2003-01-02 | Lam Patrick Y. | Imidazo-heterobicycles as factor Xa inhibitors |
WO2001055119A2 (en) * | 2000-01-25 | 2001-08-02 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
WO2005019188A1 (ja) | 2003-08-22 | 2005-03-03 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
WO2006083005A1 (ja) | 2005-02-03 | 2006-08-10 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
WO2007046392A1 (ja) * | 2005-10-19 | 2007-04-26 | Kissei Pharmaceutical Co., Ltd. | 縮合複素環誘導体、それを含有する医薬組成物及びその医薬用途 |
Non-Patent Citations (4)
Title |
---|
HIROKAWA SYOTEN: "Molecular design", vol. 7, HIROKAWA BOOK STORE, article "Iyakuhin no Kaihatsu", pages: 163 - 198 |
IGAKUSYOIN: "Hyojun Seirigaku", pages: 882 - 891 |
SANKA TO FUJINKA, vol. 71, no. 3, 2004, pages 280 - 285 |
See also references of EP2147922A4 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225067A (zh) * | 2011-04-29 | 2011-10-26 | 济南环肽医药科技有限公司 | 一种治疗胃癌的药物组合物 |
CN102225067B (zh) * | 2011-04-29 | 2012-10-03 | 济南环肽医药科技有限公司 | 一种治疗胃癌的药物组合物 |
WO2014030743A1 (ja) | 2012-08-24 | 2014-02-27 | 武田薬品工業株式会社 | 複素環化合物 |
CN104755465A (zh) * | 2012-08-24 | 2015-07-01 | 武田药品工业株式会社 | 杂环化合物 |
WO2014042176A1 (ja) * | 2012-09-14 | 2014-03-20 | キッセイ薬品工業株式会社 | 縮合複素環誘導体の製造方法およびその製造中間体 |
JPWO2014042176A1 (ja) * | 2012-09-14 | 2016-08-18 | キッセイ薬品工業株式会社 | 縮合複素環誘導体の製造方法およびその製造中間体 |
CN115232144A (zh) * | 2021-04-22 | 2022-10-25 | 长春金赛药业有限责任公司 | 含氮稠环类衍生物、药物组合物及其制备方法和应用 |
CN115232144B (zh) * | 2021-04-22 | 2024-04-02 | 长春金赛药业有限责任公司 | 含氮稠环类衍生物、药物组合物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CA2682519A1 (en) | 2008-11-06 |
JPWO2008133127A1 (ja) | 2010-07-22 |
EP2147922A1 (en) | 2010-01-27 |
EP2147922A4 (en) | 2012-04-18 |
EP2147922B1 (en) | 2017-08-02 |
US8426427B2 (en) | 2013-04-23 |
US20100081674A1 (en) | 2010-04-01 |
JP5352449B2 (ja) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200732309A (en) | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | |
MX2009010296A (es) | Derivado de anillo fusionado nitrogenado, composicion farmaceutica que lo contiene, y uso del mismo para propositos medicos. | |
GEP20156348B (en) | Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators | |
TNSN08283A1 (en) | Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use | |
PE20130385A1 (es) | Derivados del acido naft-2-ilacetico para tratar el sida | |
MX2010014234A (es) | Compuestos pirazol 436. | |
TW200626553A (en) | Novel compounds | |
NZ627827A (en) | Antiviral combinations involving (3s, 11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide | |
NZ593951A (en) | Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators | |
EA201270738A1 (ru) | Модуляторы фармакокинетических свойств лекарственных средств | |
SE0402735D0 (sv) | Novel compounds | |
WO2008133128A1 (ja) | 縮合複素環誘導体、それを含有する医薬組成物及びその医薬用途 | |
HK1129376A1 (en) | Novel imidazole derivatives, preparation and user thereof as medicine | |
MX2009003227A (es) | Moduladores de los receptores de glutamato metabotropicos 5(mglur5). | |
MX2009012613A (es) | Tiazoles substituidos por heteroarilo y su uso como agentes antivirales. | |
GEP20156368B (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2008133127A1 (ja) | 縮合へテロ環誘導体、それを含有する医薬組成物及びその医薬用途 | |
WO2008011110A3 (en) | Di-amino-substituted heterocyclic compounds and methods of use | |
TW200806291A (en) | Pharmaceutical formulations | |
GEP20135913B (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereat treatment of diseases based on mcp-1 and cx3cr1 expression | |
TW200634001A (en) | Novel compounds | |
TW200616635A (en) | Novel compounds | |
WO2009060952A1 (ja) | 新規製剤 | |
GEP20156332B (en) | Pyrazoles as crth2 antagonists | |
SE0401655D0 (sv) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08740472 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009511815 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2682519 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12595931 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2008740472 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008740472 Country of ref document: EP |